Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE ROCHE : revenue, balance sheet and financial ratios

PHARMACIE ROCHE is a French company founded 7 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in VARENNES-SUR-ALLIER (03150), this company of category PME shows in 2022 a revenue of 2.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE ROCHE (SIREN 848956363)
Indicator 2024 2023 2022 2021 2020
Revenue N/C N/C 2 731 945 € N/C N/C
Net income 251 604 € 225 693 € 290 158 € 271 360 € 326 100 €
EBITDA N/C N/C 320 553 € N/C N/C
Net margin N/C N/C 10.6% N/C N/C

Revenue and income statement

En 2024, PHARMACIE ROCHE genera un resultado neto positivo de 252 k€. Evolución 2020-2024: 326 k€ -> 252 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

251 604 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

El ratio de endeudamiento (= Deuda financiera / Fondos propios x 100) se sitúa en 69%. La deuda permanece bajo control. La autonomía financiera (= Fondos propios / Total activo x 100) alcanza el 52%. Esta alta autonomía significa que la empresa financia la mayoría de sus activos con fondos propios.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

68.855%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

52.432%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

64.8%

Solvency indicators evolution
PHARMACIE ROCHE

Sector positioning

Ratio de endeudamiento
68.86 2024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average -11 pts over 3 years

En 2024, el ratio de endeudamiento de PHARMACIE ROCHE (68.86) se sitúa por encima de la mediana del sector. Este ratio mide el peso de la deuda en relación con el patrimonio. Un esfuerzo de reducción podría mejorar la solidez financiera.

Autonomía financiera
52.43% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Bueno +16 pts over 3 years

En 2024, el autonomía financiera de PHARMACIE ROCHE (52.4%) se sitúa por encima de la mediana del sector. Este ratio representa la parte del patrimonio en la financiación total. Esta posición cómoda ofrece un margen de seguridad apreciable.

Capacidad de reembolso
4.4 ans 2022
2022
Q1: 1.29 ans
Med: 3.55 ans
Q3: 6.63 ans
Average

En 2022, el capacidad de reembolso de PHARMACIE ROCHE (4.4 ans) se sitúa por encima de la mediana del sector. Este ratio indica el número de años necesarios para pagar la deuda con flujo de caja. Un esfuerzo de reducción podría mejorar la solidez financiera.

Liquidity ratios

El ratio de liquidez se sitúa en 350.06. La empresa tiene 2€ de activos líquidos por cada 1€ de deuda a corto plazo.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

350.059

Liquidity indicators evolution
PHARMACIE ROCHE

Sector positioning

Ratio de liquidez
350.06 2024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Excelente

En 2024, el ratio de liquidez de PHARMACIE ROCHE (350.06) se sitúa en el top 25% del sector. Este ratio mide la capacidad de cubrir deuda a corto plazo con activos corrientes. Un ratio superior a 1 asegura cobertura cómoda de vencimientos a corto plazo.

Cobertura de intereses
3.71x 2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Bueno

En 2022, el cobertura de intereses de PHARMACIE ROCHE (3.7x) se sitúa por encima de la mediana del sector. Este ratio indica cuántas veces el resultado operativo cubre los gastos de intereses. Esta posición cómoda ofrece un margen de seguridad apreciable.

Working capital requirement (WCR) and payment terms

El fondo de maniobra operativo (FM) mide el desfase temporal de tesorería.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE ROCHE

Positioning of PHARMACIE ROCHE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE ROCHE is estimated at 3 512 577 € (range 2 446 103€ - 5 255 017€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
2446k€ 3512k€ 5255k€
3 512 577 € Range: 2 446 103€ - 5 255 017€
NAF 5 année 2024

Valuation method used

Net Income Multiple
251 604 € × 14.0x = 3 512 578 €
Range: 2 446 104€ - 5 255 017€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE ROCHE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE ROCHE

What is the revenue of PHARMACIE ROCHE ?

The revenue of PHARMACIE ROCHE in 2022 is 2.7 M€.

Is PHARMACIE ROCHE profitable?

Yes, PHARMACIE ROCHE generated a net profit of 252 k€ in 2024.

Where is the headquarters of PHARMACIE ROCHE ?

The headquarters of PHARMACIE ROCHE is located in VARENNES-SUR-ALLIER (03150), in the department Allier.

Where to find the tax return of PHARMACIE ROCHE ?

The tax return of PHARMACIE ROCHE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE ROCHE operate?

PHARMACIE ROCHE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.